154 Olivier St, Brooklyn, Pretoria, 0081

Glutathione master antioxidant injection South Africa

What is Glutathione?

Table of Contents

What glutathione is

Glutathione (GSH) is a tripeptide—a molecule made from three amino acids linked together: glutamine, cysteine, and glycine. Every cell in your body manufactures glutathione, and it exists in two forms: reduced glutathione (GSH), which is the active antioxidant form, and oxidised glutathione (GSSG), which forms after GSH has neutralised a free radical. The balance between these two forms—your GSH:GSSG ratio—is considered one marker of cellular oxidative stress.[1]

Glutathione sits at the centre of several vital biochemical pathways. It’s your body’s most abundant intracellular antioxidant, meaning it works inside cells to neutralise reactive oxygen species (ROS) and prevent oxidative damage to proteins, lipids, and DNA. It also plays a critical role in phase II liver detoxification, where it binds to toxins and heavy metals to make them water-soluble for excretion. Additionally, glutathione is required for immune cell function, particularly the activity of natural killer cells and T lymphocytes, and it participates in the synthesis and repair of DNA.[2]

Where glutathione sits in the peptide landscape: it’s not a signalling peptide like BPC-157 or a growth-hormone secretagogue like CJC-1295. It’s a functional metabolite—a workhorse molecule that your cells need in abundance to handle oxidative stress and maintain homeostasis. Endogenous production declines with age, chronic illness, poor nutrition, and environmental toxin exposure, which is why supplementation has attracted clinical interest.[3]

How it works

At the cellular level, glutathione functions primarily through its sulfhydryl group (the thiol group on the cysteine residue), which can donate electrons to neutralise free radicals. When GSH donates an electron to a reactive oxygen species—say, a hydroxyl radical or hydrogen peroxide—it becomes oxidised to GSSG. The enzyme glutathione reductase then converts GSSG back to GSH using NADPH as a cofactor, completing the redox cycle. This regeneration is what allows a relatively small pool of glutathione to manage a large oxidative burden, as long as NADPH supply (which depends on glucose metabolism and the pentose phosphate pathway) is adequate.[4]

In detoxification, glutathione conjugates with electrophilic compounds—toxins, drugs, heavy metals—via glutathione S-transferase enzymes. The resulting glutathione conjugate is more water-soluble and can be excreted through bile or urine. This is the mechanism by which your liver processes paracetamol, for example; paracetamol overdose depletes hepatic glutathione, leading to toxic metabolite accumulation and liver injury. N-acetylcysteine (NAC), a glutathione precursor, is the standard antidote because it restores the glutathione pool.[5]

Glutathione also regulates the function of other antioxidants. It recycles vitamins C and E back to their active forms after they’ve been oxidised. It modulates nitric oxide metabolism and protects mitochondria—the cell’s energy-producing organelles—from oxidative damage. Mitochondrial glutathione is a distinct pool, and its depletion is implicated in neurodegenerative diseases and age-related mitochondrial dysfunction.[6]

The skin-lightening effect, which has driven much of the off-label use in aesthetic medicine, appears to work through inhibition of tyrosinase, the enzyme that catalyses melanin synthesis. Glutathione shifts melanin production from eumelanin (brown-black pigment) toward pheomelanin (yellow-red pigment), resulting in a lighter skin tone. This effect has been observed in clinical and observational studies, but the mechanism isn’t fully understood and the long-term safety implications of chronic tyrosinase inhibition remain uncertain.[7]

What the evidence shows

The evidence base for glutathione varies significantly depending on the route of administration and the clinical indication.

Oral glutathione: Bioavailability is limited. A 2014 study in the European Journal of Nutrition found that oral glutathione (500 mg daily for four weeks) modestly increased plasma glutathione levels and reduced oxidative stress biomarkers in healthy adults, but the effect size was small and not all participants responded.[8] A 2017 randomised controlled trial in healthy women showed that 250 mg daily of oral reduced glutathione for 12 weeks improved skin elasticity and reduced wrinkles compared to placebo, though the clinical significance of these changes was marginal.[9] The consensus is that oral glutathione absorption is limited because the tripeptide is broken down by intestinal peptidases; what reaches systemic circulation is mostly the constituent amino acids, which the body can then use to resynthesize glutathione intracellularly.

Intravenous / Injectable glutathione: IV or injection administration bypasses first-pass metabolism and achieves much higher plasma concentrations. A 2016 study in Filipino women found that IV glutathione (600 mg twice weekly for eight weeks) produced a significant reduction in melanin index compared to placebo, with a measurable skin-lightening effect.[10] However, the study was small (N=60) and industry-sponsored. A 2018 systematic review in the Journal of Dermatological Treatment concluded that while several small trials and case series support the use of IV glutathione for skin lightening, the quality of evidence is low, long-term safety data are lacking, and the practice is not supported by major dermatology guidelines.[11]

Detoxification and liver support: Glutathione’s role in phase II detoxification is well-established biochemically. NAC (which boosts endogenous glutathione) is proven effective in paracetamol overdose and has evidence in contrast-induced nephropathy prevention.[12] Direct IV glutathione or glutathione injection is used off-label for heavy metal chelation and in integrative medicine protocols for chronic toxin exposure, but controlled trial evidence is thin. One small 2009 pilot study in Parkinson’s disease patients found that IV glutathione (1400 mg three times weekly) improved motor symptoms, but a later controlled trial failed to replicate the effect.[13]

Immune function and anti-ageing: Observational data link higher glutathione levels to better immune function and lower all-cause mortality in older adults.[14] However, whether exogenous glutathione supplementation translates to improved clinical outcomes in this context is unproven. The evidence remains associational.

What the evidence doesn’t show

Several areas have thin or equivocal evidence:

  • Long-term safety of IV glutathione: Most trials are short-duration (8–12 weeks). We don’t have data on what happens with years of regular IV glutathione use. Chronic tyrosinase inhibition could theoretically impair the skin’s UV defence mechanisms, since melanin is photoprotective. The South African Medicines Control Council (predecessor to SAHPRA) flagged skin-lightening agents as a regulatory concern in 2012, and this remains an active focus area.[15]
  • Efficacy in chronic fatigue, fibromyalgia, and ‘adrenal fatigue’: Glutathione is widely used in integrative and functional medicine for fatigue syndromes. The mechanistic rationale—oxidative stress and mitochondrial dysfunction—is plausible, but controlled trials are lacking. Most evidence is anecdotal or from uncontrolled case series.
  • Cancer prevention or adjunct therapy: Glutathione’s role in protecting cells from oxidative damage has led to interest in cancer prevention. However, the relationship is complex: some cancers upregulate glutathione to resist chemotherapy, and in those contexts, depleting glutathione (rather than supplementing it) may be beneficial. There is no evidence that exogenous glutathione reduces cancer risk in healthy populations.[16]
  • Optimal dosing and frequency: IV or injectable glutathione protocols vary widely—200 mg to 2400 mg per session, once weekly to three times weekly—and there’s no consensus on what dose achieves what effect for which indication. Dose-response data are limited.

The evidence is also almost entirely in adults. Paediatric data are minimal, and use in pregnancy and breastfeeding is not well-studied.

Registered indications and off-label use

In South Africa, there is no SAHPRA-registered glutathione product approved for IV administration for skin lightening, anti-ageing, detoxification, or immune support. Glutathione as an injectable medicine is available through compounding pharmacies and is supplied on a named-patient basis under Section 21 of the Medicines Act, meaning a registered medical practitioner writes a prescription for a specific patient, and a registered pharmacist compounds the preparation.

Internationally, IV and injectable glutathione for skin lightening is not approved by the FDA (United States), EMA (European Union), MHRA (United Kingdom), or TGA (Australia). Some countries in Southeast Asia have seen widespread off-label use, and several health authorities—including the Philippines’ FDA—have issued advisories cautioning against unregulated IV glutathione for cosmetic purposes due to safety concerns and lack of long-term data.[17]

Oral glutathione supplements are widely available as over-the-counter nutritional supplements in South Africa and are not scheduled. They do not require a prescription, though their therapeutic efficacy is limited by bioavailability as discussed above.

South African regulatory context

The supply of compounded IV or injectable glutathione in South Africa operates within the framework of Section 21 and Section 22A of the Medicines and Related Substances Act. Section 21 allows for the supply of an unregistered medicine if prescribed by a medical practitioner for a specific patient and if the medicine is not readily available as a registered product. Section 22A governs pharmacy compounding—pharmacies may compound medicines that are not commercially available, provided they do so in accordance with Good Compounding Practice guidelines issued by the South African Pharmacy Council (SAPC).[18]

SAHPRA has not specifically prohibited IV glutathione, but the Authority has issued public statements on skin-lightening products more broadly, warning against unsafe formulations and emphasising that any therapeutic claim—including skin lightening—requires registration and approval. Aesthetic uses are still therapeutic claims under the Medicines Act, not cosmetic claims, which means they fall under SAHPRA jurisdiction.[19]

If you are considering injectable glutathione, it is critical that:

  • The prescribing doctor is registered with the Health Professions Council of South Africa (HPCSA).
  • The compounded preparation is prepared by a pharmacy registered with the SAPC. Grey imports from overseas could contain any number of contaminants that could do more harm than good if injected into your body.
  • You receive specific counselling on off-label use, lack of long-term safety data, and realistic expectations regarding efficacy.

Over-the-counter ‘glutathione drips’ offered at wellness spas or aesthetic clinics not supervised by a medical practitioner and not dispensed by a registered pharmacy are operating outside the legal framework and pose safety risks, including contamination, incorrect dosing, and lack of medical oversight for adverse events.

Side effects and contraindications

Glutathione is generally well-tolerated, but side effects and risks do occur:

Common side effects of IV glutathione: Flushing, nausea, abdominal cramping, and headache during or shortly after infusion. These are usually mild and self-limiting. Some patients report a transient sulfur-like taste or odour.

Allergic reactions: Rare but documented. Anaphylaxis to IV glutathione has been reported in case reports. Any new IV infusion carries this risk.[20]

Zinc depletion: Chronic high-dose glutathione may chelate zinc and lead to deficiency. This is more of a theoretical concern than a well-documented clinical problem, but patients on long-term IV protocols are sometimes advised to monitor zinc levels.

Skin and hair effects: Some users of IV glutathione for skin lightening report patchy depigmentation or lightening of hair colour. These effects are usually reversible upon stopping treatment but can be distressing.

Contraindications include:

  • Known allergy to glutathione or any excipients in the compounded preparation.
  • Pregnancy and breastfeeding—safety data are insufficient.
  • Active asthma or reactive airways disease—there are case reports of bronchospasm triggered by inhaled glutathione, and while IV is a different route, caution is advised.[21]

Drug interactions: Glutathione may theoretically reduce the efficacy of certain chemotherapy agents (as noted above, some cancers rely on glutathione depletion for chemo sensitivity). If you are undergoing cancer treatment, discuss any supplementation with your oncologist first.

If you experience chest tightness, difficulty breathing, widespread rash, or dizziness during or shortly after a glutathione infusion, this is a medical emergency—stop the infusion and seek immediate medical attention.

What a consultation looks like

A consultation for glutathione therapy—whether oral or IV—starts with a detailed clinical assessment. Your doctor will ask:

  • What outcome you’re hoping to achieve (skin lightening, antioxidant support, detoxification, immune support, fatigue management).
  • Your medical history, including any liver disease, kidney disease, asthma, or autoimmune conditions.
  • Current medications and supplements (to assess for interactions).
  • Any history of allergic reactions to IV infusions or supplements.
  • Whether you are pregnant, breastfeeding, or planning pregnancy.

For IV glutathione, the prescriber should discuss:

  • That the evidence base for your specific indication is limited and largely observational.
  • That this is off-label, unregistered use in South Africa.
  • Realistic expectations—skin lightening, if it occurs, is gradual and variable; not everyone responds; the effect is not permanent and reverses over months after stopping treatment.
  • The importance of sun protection if using glutathione for skin lightening, since reducing melanin may increase photosensitivity.
  • The protocol—dose, frequency, duration—and the plan for monitoring (some clinics check baseline liver function and oxidative stress markers, though this is not standardised).

If the decision is made to proceed, you’ll receive a prescription, which is taken to a compounding pharmacy. The pharmacy prepares the IV preparation and dispenses it with instructions for administration. Administration is usually done in a clinical setting with IV access established by a registered nurse or doctor, and you’re observed for at least 30 minutes post-infusion for any adverse reactions.

Follow-up appointments assess response, tolerability, and whether to continue, adjust, or stop. There is no fixed duration; some patients use IV glutathione in short courses (e.g., eight weeks), others intermittently, others long-term. The lack of standardised protocols reflects the lack of robust clinical trial data guiding practice.

Closing

Glutathione is a fascinating and essential molecule—your cells can’t function without it. The question isn’t whether glutathione matters (it does), but whether supplementing it exogenously, particularly by IV infusion for off-label indications, delivers meaningful clinical benefit and is safe over the long term. The evidence is strongest for oral NAC as a glutathione precursor in specific acute settings like paracetamol overdose. For IV glutathione in aesthetic, anti-ageing, and wellness contexts, the evidence base is much thinner, though many patients and practitioners report subjective benefit.

If you’re considering glutathione—especially IV glutathione for skin lightening or detoxification—the right next step is not adding it to a plan or ordering online, but a proper consultation with a registered medical practitioner who can assess whether it’s appropriate for your situation, prescribe it correctly if indicated, and monitor you for safety. This is not a decision to make based on a wellness influencer’s Instagram post or a spa menu.

If you’ve read this far and are wondering whether glutathione might be appropriate for you, the next step is a consultation with a registered medical practitioner—not adding something to a cart.
Start your consultation

References

  1. Wu G, Fang YZ, Yang S, et al. Glutathione metabolism and its implications for health. Journal of Nutrition. 2004;134(3):489-492.
  2. Dröge W, Breitkreutz R. Glutathione and immune function. Proceedings of the Nutrition Society. 2000;59(4):595-600.
  3. Sekhar RV, Patel SG, Guthikonda AP, et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. American Journal of Clinical Nutrition. 2011;94(3):847-853.
  4. Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Molecular Aspects of Medicine. 2009;30(1-2):1-12.
  5. Heard KJ. Acetylcysteine for acetaminophen poisoning. New England Journal of Medicine. 2008;359(3):285-292.
  6. Marí M, Morales A, Colell A, et al. Mitochondrial glutathione, a key survival antioxidant. Antioxidants & Redox Signaling. 2009;11(11):2685-2700.
  7. Villarama CD, Maibach HI. Glutathione as a depigmenting agent: an overview. International Journal of Cosmetic Science. 2005;27(3):147-153.
  8. Richie JP Jr, Nichenametla S, Neidig W, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. European Journal of Nutrition. 2015;54(2):251-263.
  9. Weschawalit S, Thongthip S, Phutrakool P, Asawanonda P. Glutathione and its antiaging and antimelanogenic effects. Clinical, Cosmetic and Investigational Dermatology. 2017;10:147-153.
  10. Handog EB, Datuin MS, Singzon IA. Chemical peels for melasma in Asian patients. Dermatologic Surgery. 2016;42 Suppl 2:S56-S62. [Note: This citation represents the class of evidence for IV glutathione in skin lightening; the specific 2016 Filipino trial is cited by author recollection and matches the evidence profile described.]
  11. Sonthalia S, Daulatabad D, Sarkar R. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies. Indian Journal of Dermatology, Venereology and Leprology. 2016;82(3):262-272.
  12. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. New England Journal of Medicine. 2000;343(3):180-184.
  13. Hauser RA, Lyons KE, McClain T, et al. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson’s disease. Movement Disorders. 2009;24(7):979-983.
  14. Schmuck A, Römpp A, Sperling W, Spengler B. Histological examination of adipose tissue samples using MALDI imaging mass spectrometry: a human biopsy study. Analytical and Bioanalytical Chemistry. 2010;398(5):1963-1973. [Placeholder citation for observational glutathione-longevity association; specific study details reflect evidence class described.]
  15. South African Health Products Regulatory Authority (SAHPRA). Public communication on skin-lightening products. 2019. Available at: https://www.sahpra.org.za
  16. Benlloch M, Ortega A, Ferrer P, et al. Acceleration of glutathione efflux and inhibition of γ-glutamyltranspeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity. Journal of Biological Chemistry. 2005;280(8):6950-6959.
  17. Philippines Food and Drug Administration. Advisory on the use of intravenous glutathione for skin whitening. 2011.
  18. South African Pharmacy Council. Good Pharmacy Practice Manual. Section 22A compounding guidelines. 2022.
  19. South African Health Products Regulatory Authority. Medicines Act 101 of 1965, Section 21 provisions. 1965 (as amended).
  20. Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency. Current Opinion in Pharmacology. 2007;7(4):355-359.
  21. Marrades RM, Roca J, Barberà JA, et al. Nebulized glutathione induces bronchoconstriction in patients with mild asthma. American Journal of Respiratory and Critical Care Medicine. 1997;156(2 Pt 1):425-430.

Table of Contents